$IMPL starting to build a base...
This company has a solid future, Q1 2022 should be a good quarter for sales on their migraine medication delivered through a nasal spray. I like the stock in 2022 as a potential to double or more. Will be on watch for a play.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.